Research progress in targeted chemotherapy for thyroid cancer

doi:10.19401/j.cnki.1007-3639.2017.06.009

Abstract

Abstract: Due to the limited efficacy of traditional therapies, the risk of death in patients with advanced thyroid cancer remains high. In recent years, targeted chemotherapy has shown prospective effects on inhibiting the growth of thyroid cancer and prolonging progression-free survival in these patients, but also brings some clinical confusion. Consequently, this paper reviewed the application status and clinical problems of targeted chemotherapy in thyroid cancer. In addition, treatment strategies of thyroid cancer and the future perspectives were also presented.

Key words: Thyroid cancer, Targeted chemotherapy, Kinase inhibitor

JIN Yuchen, CHEN Libo. Research progress in targeted chemotherapy for thyroid cancer[J]. China Oncology, 2017, 27(6): 451-458.

[1]	CHEN Guo , HAN Pengli , CHEN Keru , LI Mingchuang , ZHANG Qingsong , CHEN Zheng , DONG Hanhua , QIAN Yuejun , LÜ Jing . Molecular mechanism of miR-19b-3p regulating apoptosis of medullary thyroid cancer cells by targeting MTUS1 [J]. China Oncology, 2021, 31(5): 390-396.
[2]	YUAN Hao , JIANG Xiaofei , YOU Qinghua , ZHU Hongbo , YE Huiying , WU Wen , QIAN Fengyuan , ZHONG Ming , LI Yongping . Clinical application of fine needle puncture Diff-Quik staining for the differentiation and protection of parathyroid glands in thyroid carcinoma surgery [J]. China Oncology, 2021, 31(4): 302-307.
[3]	WU Yuanyuan , WANG Jun , LIU Qinjiang , ZHANG Ming . Analysis of prognostic factors and treatment strategies of anaplastic thyroid carcinoma [J]. China Oncology, 2021, 31(3): 212-220.
[4]	WANG Ming, CAO Hui. Recent advances in drug therapy for advanced gastrointestinal stromal tumor [J]. China Oncology, 2021, 31(2): 90-99.
[5]	ZHAO Yuanyuan , ZHOU Jianying , FAN Yun , WANG Jialei , HUANG Dingzhi , LI Junling , SHI Meiqi , LIU Jiwei , YAO Yu , WU Lin , YAO Wenxiu , ZHANG Li . Advances in the treatment of BRAF V600-mutant non-small cell lung cancer [J]. China Oncology, 2021, 31(12): 1145-1152.
[6]	WU Hongwen, MEI Yan, WANG Qiao, YUAN Jia, ZHAO Liwei. The clinical value of serum MIP-1α and S-TK1 in the evaluation of postoperative radioactive ¹³¹ I treatment for thyroid carcinoma [J]. China Oncology, 2021, 31(11): 1088-1095.
[7]	LI Min, WEN Peng, QIAN Qiuqin, QIN Ang, ZENG Li, SHI Feng. Clinical study of iodine-125 seeds implantation in the treatment of lymph node metastasis of radioactive iodine- refractory differentiated thyroid cancer [J]. China Oncology, 2020, 30(2): 122-127.
[8]	MU Zhuanzhuan , LI Zheng , ZHANG Xin , LIN Yansong . The effect of empiric ¹³¹ I therapy in papillary thyroid cancer patients with pulmonary metastasis [J]. China Oncology, 2020, 30(12): 991-995.
[9]	REN Junling , CHEN Bin , TANG Xiaolei . Research on the correlation between BMI and pathologic factors of papillary thyroid carcinoma [J]. China Oncology, 2020, 30(12): 1041-1045.
[10]	YANG Lingge, WANG Chunmeng. Drug therapy for alveolar soft part sarcoma: current status and progress [J]. China Oncology, 2019, 29(9): 746-752.
[11]	YANG Ke, ZHENG Rong, LIN Yansong. The interpretation of management guidelines for children with thyroid nodules and differentiated thyroid cancer: radioactive iodine therapy and new progress [J]. China Oncology, 2019, 29(6): 401-411.
[12]	ZHANG Liyang, LIU Chunhao, CAO Yue, LIU Hongfeng, GAO Weisheng, LI Xiaoyi. Experiences of 125 cases of re-operated persistent/recurrent differentiated thyroid cancer [J]. China Oncology, 2019, 29(6): 412-417.
[13]	GAO Luying, LIN Yansong, JIANG Yuxin, LI Jianchu, LI Hui, ZHANG Bo, LIU Ruyu, XI Xuehua, GAO Qiong, WANG Ying, ZHAO Ruina. Evaluation of short-term efficacy of apatinib using cervical ultrasound and thyroglobulin in the treatment of progressive radioactive iodine-refractory differentiated thyroid cancer [J]. China Oncology, 2019, 29(6): 418-422.
[14]	ZHANG Na, LIN Yansong, LIANG Jun. The clinical significance of thyroglobulin antibody measurement in 131I therapy of differentiated thyroid carcinoma [J]. China Oncology, 2019, 29(6): 452-456.
[15]	CHEN Junhui, ZHANG Man, LIU Shuipeng, MA Lin, LIU Yang, LI Xiaosong, MENG Jian, LI Jie, ZHANG Shuhua. The research on risk prediction of thyroid cancer based on ultrasonic characteristic multivariate logistic regression coefficient β composite score method [J]. China Oncology, 2019, 29(4): 289-293.

Research progress in targeted chemotherapy for thyroid cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments